George Scangos

George A. Scangos is the founder of Rezo Therapeutics, Inc., founded in 2022, serving as Chairman since 2023.
Current jobs include Vice Chairman at Fondation Santé since 2011, Independent Director at Agilent Technologies, Inc. since 2011, Director at Biomedical Sciences Careers Program, Inc., Independent Director at Voyager Therapeutics, Inc. since 2023, Director at Octave Bioscience, Inc. since 2018, Venture Partner at ARCH Venture Partners LLC, Trustee at Cornell University, Analyst at IS Yatirim Menkul.
Degerler.
AS (Broker), Member-National Board of Visitors at UC Davis School of Medicine, Member-Overseers Board at the University of California, and Trustee at Life Science Cares, Inc. Former jobs include Chief Executive Officer & Director at Biogen, Inc. from 2010 to 2017, Chief Executive Officer at Biogen Idec New Ventures, Inc., Chief Executive Officer at Biogen Idec, Inc. (North Carolina) from 2010 to 2017, Chairman at Anadys Pharmaceuticals, Inc. from 2003 to 2010, Chairman at Pharmaceutical Research & Manufacturers of America from 2016 to 2017, Chairman at California Healthcare Institute, Director at Onyx Pharmaceuticals, Inc. from 2000 to 2005, Director at Exelixis, Inc. from 2010 to 2020, Non-Executive Director at Entelos, Inc. from 1997 to 2010, Director at Global Alliance for TB Drug Development from 2006 to 2010, Director at Vir Biotechnology, Inc. from 2023 to 2025, Director at Taconic Biosciences GmbH, Director at Symphony Evolution, Inc., Director at Baybio Institute, Director at Decibel Therapeutics, Inc., President-Biotechnology Division at Bayer Corp.
from 1993 to 1996, Professor at The Johns Hopkins University, Senior Vice President-Research & Development at Bayer, Inc. from 1987 to 1996, Trustee at Museum of Science, and President at Bayer Biotechnology from 1993 to 1996.
Education includes undergraduate degree from Cornell University and doctorate from the University of Massachusetts.